|
On The Fly
|
Check out this evening's… ShowHide Related Items >><< - 03/02/21
- Vectrus reports backlog as of December 31, 2020, $5.1B
- 02/15/21
- Vectrus awarded prime contract for Department of Defense Naval Base Coronado
- 01/04/21
- Vectrus acquires HHB Systems, terms not disclosed
- 12/29/20
- Vectrus awarded $882.49M Army contract
- 01/12/21
- Urban Outfitters drops 11% to $27.00 after posting holiday sales decline
- 12/03/20
- Urban Outfitters appoints Melanie Marein-Efron as CFO
- 10/13/20
- Urban Outfitters announces management changes
- 03/01/21
- Stratasys expects Q1 revenue to track similarly to 1Q20
- 02/18/21
- Stratasys acquires U.K.-based RP Support Ltd., terms not stated
- 02/18/21
- Stratasys acquires RPS, provider of best-in-class' stereolithography 3D printers
- 12/09/20
- Stratasys to acquire Origin for total consideration of up to $100M
RVMD Revolution Medicines - 10/25/20
- Revolution Medicines reports progress, expansion of combo strategy with RMC-4630
- 10/12/20
- Revolution Medicines to present interim fata from Phase 1b/2 trial of RMC-4630
- 09/16/20
- Revolution Medicines reports data on KRAS-G12D(ON) inhibitors
- 03/02/21
- Ross Stores falls 5% to $111.50 after Q4 earnings miss
- 03/02/21
- Ross Stores reports Q4 SS down 6%
- 03/02/21
- Ross Stores reinstates quarterly dividend of 28.5c per share
- 02/28/21
- Fly Intel: Top five weekend stock stories
- 02/22/21
- RealReal sees Q1 gross merchandise volume $301M-$310M
- 01/13/21
- RealReal issues Luxury Consignment Report
- 12/02/20
- RealReal reports approx. 10% y/y increase in 5-day holiday period order volume
- 12/02/20
- RealReal: Business recovery continued in November
- 02/12/21
- Quanterix announces Simoa joint laboratory with WuXi AppTec
- 01/11/21
- Quanterix gets FDA emergency use authorization for COVID protein antigen test
- 12/28/20
- Quanterix gets FDA EUA for COVID antibody test with Simoa
- 12/24/20
- Quanterix gets EUA for Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody Test
- 02/22/21
- NV5 Global acquires TerraTech Engineers, terms not disclosed
- 02/11/21
- NV5 Global division launches INSITE platform
- 02/02/21
- NV5 Global awarded $5M in South Florida contracts
- 01/25/21
- NV5 Global awarded $100M engineering, design contract
MRVI Maravai Lifesciences - 02/10/21
- Maravai Lifesciences subsidiary issued patent for CleanCap technology
- 11/30/20
- Maravai Lifesciences CEO buys 35K shares of common stock
- 03/02/21
- Lyft raises Q1 adjusted EBITDA view to ($135M) from ($150M)-($145M)
- 02/10/21
- GM not planning to partner with rideshare players as EV portfolio rolls out
- 02/09/21
- Lyft jumps 5% to $56.50 per share after Q4 results
- 02/09/21
- Lyft reports Q4 active riders 12,552, down 45.2%
- 03/02/21
- Nordstrom says overall trends improved sequentially throughout the quarter
- 03/02/21
- Nordstrom says taking actions to 'significantly reduce inventory levels' in Q1
- 03/02/21
- Nordstrom says Q4 digital sales of about $2B represented 54% of business
- 03/01/21
- Nordstrom, Tonal form partnership
- 12/29/20
- iCAD to partner with Dr. Santosh Kesari evaluating its eBx system to treat GBM
- 12/10/20
- Solis Mammography adopts iCAD's ProFound AI platform
- 11/30/20
- iCAD highlights suite of breast health AI solutions at RSNA 2020
- 11/25/20
- iCAD announces data on treatment of early-stage breast, gynelogical cancers
- 03/02/21
- Grocery Outlet sees FY21 EBITDA margins in line with 2019 performance
- 03/02/21
- Grocery Outlet sees Q1 comparable sales down high single digits
- 11/10/20
- Grocery Outlet to open 34 stores this year, no additional closures planned
- 03/02/21
- FuboTV falls 5% to $39.91 after Q4 earnings miss
- 03/02/21
- FuboTV reports Q4 subscription revenue up 91% to $91.4M
- 02/22/21
- Discovery says recognized 126M total gain on FuboTV investment
- 02/16/21
- Greenlight Capital buys FuboTV and Danimer Scientific, exits Intel
- 02/16/21
- Cooperman's Omega Advisors buys GM, exits Lee in Q4
- 12/23/20
- B&G Foods recalls individual containers of Food Club Garlic Powder
- 12/01/20
- B&G Foods sees accretion from acquisition of J. M. Smucker's Crisco oils
- 11/16/20
- B&G Foods CEO Kenneth Romanzi to step aside, David Wenner named interim CEO
ARNA Arena Pharmaceuticals - 03/02/21
- Arena Pharmaceuticals slides after IBS trial did not meet primary endpoint
- 03/02/21
- Arena Pharmaceuticals reports topline results from Phase 2b CAPTIVATE trial
- 02/02/21
- Arena Pharmaceuticals completes enrollment of ELEVATE UC 52 trial
- 12/08/20
- Arena Pharmaceuticals achieves target enrollment for Phase 3 ELEVATE UC 52 trial
- 03/02/21
- Ambarella jumps 7% to $121.95 after Q4 results top estimates
- 03/02/21
- Motional selects Ambarella CVflow AI processors for driverless vehicles
- 01/11/21
- Ambarella unveils CV5 AI vision processor with 8K capabilities
- 12/28/20
- FAA adopts final rules for drones 'advancing opportunities' for utilization
- 02/25/21
- Airbnb rallies 3% to $186.66 after revenue beats expectations
- 02/25/21
- Airbnb sees 2021 capital expenditures higher than 2020
- 02/25/21
- Airbnb sees adjusted EBITDA margins lower in first half than second
- 01/13/21
- Airbnb to cancel reservations in D.C. area during Inauguration week
MRVI Maravai Lifesciences - 02/10/21 KeyBanc
- Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
- 12/16/20 KeyBanc
- Maravai Lifesciences initiated with an Overweight at KeyBanc
- 12/15/20 Morgan Stanley
- Maravai Lifesciences initiated with an Overweight at Morgan Stanley
- 12/15/20 Baird
- Baird starts Maravai Lifesciences at Outperform with $31 price target
- 02/24/21 Deutsche Bank
- Ambarella price target raised to $100 from $75 at Deutsche Bank
- 01/21/21 Stifel
- Ambarella price target raised to $118 from $110 at Stifel
- 01/13/21 Roth Capital
- Ambarella upgraded to Buy with $130 price target at Roth Capital
- 01/13/21 Roth Capital
- Ambarella upgraded to Buy from Neutral at Roth Capital
- 01/27/21 SVB Leerink
- Quanterix price target raised to $75 from $50 at SVB Leerink
- 01/14/21 Canaccord
- Quanterix price target raised to $74 from $60 at Canaccord
- 01/12/21 Canaccord
- Quanterix price target raised to $60 from $54 at Canaccord
- 10/19/20 SVB Leerink
- Quanterix price target raised to $48 from $37 at SVB Leerink
- 02/11/21 KeyBanc
- Uber price target raised to $75 from $63 at KeyBanc
- 02/11/21 Needham
- Needham transfers coverage on Lyft, raises price target $70 from $50
- 02/10/21 DA Davidson
- Lyft price target raised to $66 from $58 at DA Davidson
- 02/10/21 Jefferies
- Lyft price target raised to $75 from $70 at Jefferies
- 02/01/21 Wedbush
- FuboTV price target raised to $50 from $40 at Wedbush
- 01/21/21 Barrington
- FuboTV initiated with an Outperform at Barrington
- 01/19/21 LightShed Partners
- FuboTV price target lowered to $6.50 from $8 at LightShed Partners
- 01/12/21 Roth Capital
- FuboTV 'adds another piece to gaming puzzle' with deal, says Roth Capital
- 01/19/21 Stephens
- B&G Foods initiated with an Equal Weight at Stephens
- 01/05/21 Credit Suisse
- B&G Foods downgraded to Underperform from Neutral at Credit Suisse
- 07/28/20 Seaport Global
- B&G Foods initiated with a Neutral at Seaport Global
- 06/12/20
- Fly Intel: Top five analyst initiations
- 11/18/20 Berenberg
- Grocery Outlet initiated with a Buy at Berenberg
- 11/11/20 DA Davidson
- Grocery Outlet price target lowered to $50 from $53 at DA Davidson
- 08/14/20 DA Davidson
- Grocery Outlet initiated with a Buy at DA Davidson
- 08/14/20 DA Davidson
- Grocery Outlet initiated with a Buy at DA Davidson
- 05/19/20 B. Riley Securities
- B. Riley FBR sees path for Vectrus shares to top $70
- 03/05/20 B. Riley Securities
- Vectrus price target raised to $60 from $55 at B. Riley FBR
- 03/04/20 Noble Capital
- Vectrus upgraded to Outperform from Market Perform at Noble Capital
- 01/21/21 Deutsche Bank
- Ross Stores price target raised to $129 from $123 at Deutsche Bank
- 01/04/21 JPMorgan
- Ross Stores price target raised to $128 from $125 at JPMorgan
- 11/20/20 MKM Partners
- Ross Stores price target raised to $124 from $105 at MKM Partners
- 11/20/20 Loop Capital
- Ross Stores price target raised to $130 from $110 at Loop Capital
- 01/13/21 Roth Capital
- NV5 Global price target raised to $136 from $82 at Roth Capital
- 11/12/20 Roth Capital
- NV5 Global price target raised to $82 from $77 at Roth Capital
- 08/24/20
- Fly Intel: Top five analyst upgrades
- 08/24/20 Sidoti
- Sidoti upgrades NV5 Global to Buy following pullback
- 02/23/21
- Fly Intel: Top five analyst downgrades
- 02/23/21 BTIG
- RealReal price target raised to $32 from $27 at BTIG
- 02/23/21 Cowen
- RealReal price target raised to $29 from $18 at Cowen
- 02/23/21 Raymond James
- RealReal downgraded to Market Perform from Outperform at Raymond James
RVMD Revolution Medicines - 01/29/21 JPMorgan
- Revolution Medicines price target raised to $44 from $33 at JPMorgan
- 10/26/20 H.C. Wainwright
- Revolution Medicines price target raised to $54 from $52 at H.C. Wainwright
- 09/14/20 Jefferies
- Inhibrx initiated with a Buy at Jefferies
- 05/21/20
- Fly Intel: Top five analyst initiations
- 02/16/21 JPMorgan
- Nordstrom price target raised to $40 from $34 at JPMorgan
- 02/10/21 Gordon Haskett
- Nordstrom upgraded to Buy from Hold at Gordon Haskett
- 01/21/21 Deutsche Bank
- Nordstrom price target raised to $43 from $24 at Deutsche Bank
- 01/14/21 Credit Suisse
- Nordstrom price target raised to $39 from $26 at Credit Suisse
- 02/26/21 Deutsche Bank
- Urban Outfitters named short-term investment idea at Deutsche Bank
- 02/10/21 RBC Capital
- Urban Outfitters price target raised to $30 from $28 at RBC Capital
- 01/21/21 Deutsche Bank
- Urban Outfitters price target raised to $32 from $31 at Deutsche Bank
- 01/14/21
- Fly Intel: Top five analyst downgrades
ARNA Arena Pharmaceuticals - 01/28/21 JonesTrading
- Arena Pharmaceuticals initiated with a Buy at JonesTrading
- 11/19/20 SMBC Nikko
- Arena Pharmaceuticals initiated with an Outperform at SMBC Nikko
- 11/10/20 RBC Capital
- Arena Pharmaceuticals price target lowered to $76 from $80 at RBC Capital
- 11/02/20 JPMorgan
- Arena Pharmaceuticals price target raised to $90 from $71 at JPMorgan
- 01/19/21 Stifel
- Stratasys initiated with a Buy at Stifel
- 01/15/21 JPMorgan
- Stratasys downgraded to Underweight from Neutral at JPMorgan
- 10/09/20 Berenberg
- Stratasys initiated with a Buy at Berenberg
- 09/24/20
- Fly Intel: Top five analyst downgrades
- 02/26/21 B. Riley Securities
- iCAD price target raised to $23 from $18 at B. Riley Securities
- 02/25/21 Oppenheimer
- iCAD initiated with an Outperform at Oppenheimer
- 02/25/21 Craig-Hallum
- iCAD price target raised to $22 from $15 at Craig-Hallum
- 02/25/21 Lake Street
- iCAD price target raised to $21 from $17 at Lake Street
- 02/26/21 HSBC
- Airbnb price target raised to $224 from $220 at HSBC
- 02/26/21 Jefferies
- Airbnb price target raised to $210 from $170 at Jefferies
- 02/26/21 DA Davidson
- Airbnb price target raised to $210 from $172 at DA Davidson
- 02/26/21 Needham
- Airbnb represents 'best way to play travel recovery', says Needham
- 03/02/21
- Vectrus sees FY21 adjusted EPS $3.48-$4.08, consensus $3.74
- 03/02/21
- Vectrus reports Q4 adjusted EPS $1.18, consensus 92c
- 11/10/20
- Vectrus backs FY20 adjjusted EPS view $2.68-$2.82, consensus $2.63
- 11/10/20
- Vectrus reports Q3 adjustec EPS 89c, consensus 82c
- 03/02/21
- Urban Outfitters reports Q4 EPS 29c, consensus 28c
- 02/09/21
- Urban Outfitters reports preliminary Q4 revenue $1.09B, consensus $1.1B
- 01/12/21
- Urban Outfitters reports total net revenue for 2 months ended Dec 31 down 8.4%
- 01/12/21
- Urban Outfitters reports total net revenue for 2 months ended Dec 31 down 8.4%
- 03/01/21
- Stratasys reports Q4 EPS 13c, consensus 0c
- 11/12/20
- Stratasys reports Q3 non-GAAP EPS (5c), consensus (7c)
RVMD Revolution Medicines - 03/02/21
- Revolution Medicines reports Q4 EPS (52c), consensus (38c)
- 11/12/20
- Revolution Medicines reports Q3 EPS (42c), consensus (39c)
- 03/02/21
- Ross Stores sees Q1 EPS 74c-86c, consensus 89c
- 03/02/21
- Ross Stores reports Q4 EPS 67c, consensus $1.00
- 11/19/20
- Ross Stores says November month-to-date comps down mid-single-digits
- 11/19/20
- Ross Stores reports Q3 EPS $1.02 excluding 65c charge, consensus 61c
- 02/22/21
- RealReal reports Q4 EPS (49c), consensus (41c)
- 02/22/21
- Notable companies reporting after market close
- 11/09/20
- Notable companies reporting after market close
- 03/02/21
- Quanterix reports Q4 loss from operations ($11.7M) vs. ($10.8M) last year
- 03/02/21
- NV5 Global reports Q4 EPS 82c, consensus 78c
- 11/11/20
- NV5 Global reports Q3 EPS $1.13, consensus 70c
MRVI Maravai Lifesciences - 03/02/21
- Maravai Lifesciences sees FY21 EPS 80c-90c, consensus 61c
- 03/02/21
- Maravai Lifesciences reports Q4 EPS 13c, consensus 11c
- 02/09/21
- Lyft reports Q4 revenue $569.9M, consensus $562.49M
- 02/09/21
- Notable companies reporting after market close
- 12/02/20
- Lyft sees Q4 sequential revenue growth at lower end of 11%-15% range
- 11/10/20
- Lyft reports Q3 adj. EPS (89c), consensus (91c)
- 03/02/21
- Nordstrom sees FY21 revenue up more than 25%, consensus $13.46B
- 03/02/21
- Nordstrom reports Q4 EPS 21c, consensus 14c
- 03/02/21
- Nordstrom reports Q4 EPS 21c, consensus 14c
- 02/04/21
- Nordstrom gives long-term outlook, sees sales growing low single-digits annually
- 02/24/21
- iCAD reports Q4 adjusted EPS (6c), consensus (7c)
- 11/05/20
- iCAD reports Q3 EPS (7c), consensus (11c)
- 03/02/21
- Grocery Outlet reports Q4 adjusted EPS 24c, consensus 23c
- 11/10/20
- Grocery Outlet reports Q3 adj. EPS 50c, consensus 23c
- 11/10/20
- Notable companies reporting after market close
- 03/02/21
- FuboTV raises FY21 revenue view to $460M-$470M from $415M-$435M
- 03/02/21
- FuboTV sees Q1 revenue $101M-$103M, consensus $99.36M
- 03/02/21
- FuboTV reports Q4 EPS ($2.47), consensus (73c)
- 01/05/21
- FuboTV reports preliminary Q4 revenue $94M-$98M, consensus $87.36M
- 03/02/21
- B&G Foods sees FY21 revenue roughly $2.05B-$2.1B, consensus $2.03B
- 03/02/21
- B&G Foods reports Q4 adjusted EPS 35c, consensus 44c
- 11/16/20
- B&G Foods backs FY20 adjusted EPS view $2.30-$2.40, consensus $2.33
- 11/05/20
- B&G Foods sees FY20 adjusted EPS $2.30-$2.40, consensus $2.22
ARNA Arena Pharmaceuticals - 02/23/21
- Arena Pharmaceuticals reports Q4 EPS ($2.10), consensus ($1.85)
- 11/09/20
- Arena Pharmaceuticals reports Q3 EPS ($1.69), consensus ($1.87)
- 03/02/21
- Ambarella reports Q4 EPS 14c, consensus 8c
- 11/24/20
- Ambarella sees Q4 revenue $56M-$60M, consensus $52.31M
- 11/23/20
- Ambarella reports Q3 EPS 9c, consensus 5c
- 02/25/21
- Airbnb sees Q1 revenue down year-over-year
- 02/25/21
- Airbnb reports Q4 revenue $859M, consensus $747.59M
- 02/25/21
- Notable companies reporting after market close
- 02/16/21
- Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet
|
|
Hot Stocks
|
Reports Q4: Advertising… Reports Q4: Advertising revenue increased 157% YoY to $13.1M; Paid subscribers at quarter-end totaled 547,880, an increase of 73% YoY; ARPU per month was $69.19, up 17% YoY; Subscription ARPU per month was $60.72, up 13% YoY; Advertising ARPU per month was $8.47, an increase of 52% YoY; Content hours streamed by fuboTV users (paid & trial) increased 66% YoY to 205.9M; Monthly Active Users watched 127 hours per month on average, up 3% YoY. Reference Link ShowHide Related Items >><< - 02/22/21
- Discovery says recognized 126M total gain on FuboTV investment
- 02/16/21
- Greenlight Capital buys FuboTV and Danimer Scientific, exits Intel
- 01/21/21
- Greenlight discloses new positions in Resideo and NCR, discusses FuboTV stake
- 01/21/21
- Greenlight says FuboTV bear case misunderstands sports wagering opportunity
- 02/01/21 Wedbush
- FuboTV price target raised to $50 from $40 at Wedbush
- 01/21/21 Barrington
- FuboTV initiated with an Outperform at Barrington
- 01/19/21 LightShed Partners
- FuboTV price target lowered to $6.50 from $8 at LightShed Partners
- 01/12/21 Roth Capital
- FuboTV 'adds another piece to gaming puzzle' with deal, says Roth Capital
- 03/02/21
- FuboTV raises FY21 revenue view to $460M-$470M from $415M-$435M
- 03/02/21
- FuboTV sees Q1 revenue $101M-$103M, consensus $99.36M
- 03/02/21
- FuboTV reports Q4 EPS ($2.47), consensus (73c)
- 01/05/21
- FuboTV reports preliminary Q4 revenue $94M-$98M, consensus $87.36M
|